Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "UT Southwestern Medical Center"


6 mentions found


Belly fat tends to get a bad rap, but new research shows that one kind of belly fat can be healthier than others — provided you’re willing to get moving. The fat, the study found, essentially behaved differently in people with the same percentage of body fat, based on their long-term exercise habits. Regular exercisers had less rigid or fibrous fat tissue, which allows fat cells beneath the skin to expand to store fat, one of the body’s primary sources of energy. While expanding fat cells may sound like a bad thing, it’s actually better for health than having inflexible fat tissue. Another indication of this was that they had more proteins involved with fat metabolism in their fat tissue, the study found.
Persons: , , Jeffrey Horowitz, Horowitz, exercisers, Jaime Almandoz, Aayush, Rutgers Robert Wood, ” Visaria Organizations: University of Michigan School of Kinesiology, BMI, UT Southwestern Medical Center, Rutgers, Rutgers Robert Wood Johnson Medical School Locations: exercisers, nonexercisers, Dallas
Elon Musk's startup Neuralink streamed a live video on Wednesday that showed a patient using the company's brain implant to move a mouse and play chess on a computer. A BCI is a system that deciphers brain signals and translates them into commands for external technologies. Dr. Nader Pouratian, chair of the Department of Neurological Surgery at UT Southwestern Medical Center, said researchers have been developing and studying BCI technology for years. It is not clear how many patients are participating in Neuralink's trial, or what the trial is trying to demonstrate. There is reason to be hopeful about Neuralink's technology, said Dr. Marco Baptista, chief scientific officer of the Christopher & Dana Reeve Foundation, which provides resources to people who have become paralyzed.
Persons: Elon, Noland Arbaugh, Musk, Arbaugh, there's, Neuralink, Nader Pouratian, we've, Pouratian, Marco Baptista, Christopher, Dana Reeve, " Baptista Organizations: BCI, Blackrock, Neuroscience, SpaceX, Department of Neurological, UT Southwestern Medical Center, CNBC, U.S . Food, Drug Administration, Dana Reeve Foundation, PubMed Locations: Brussels, Belgium, Synchron, U.S, Neuralink
Surgeons externally attached a pig liver to a brain-dead human body and watched it successfully filter blood, a step toward eventually trying the technique in patients with liver failure. Now scientists are trying again with pigs whose organs have been genetically modified to be more humanlike. In recent years, kidneys from genetically modified pigs have been temporarily transplanted into brain-dead donors to see how well they function, and two men received heart transplants from pigs although both died within months. Political Cartoons View All 253 ImagesSome researchers also are looking to use pig livers. In a statement, the Penn team reported that the donor’s body remained stable and the pig liver showed no signs of damage.
Persons: Penn, eGenesis —, Parsia, wasn't, , ” Vagefi Organizations: University of Pennsylvania, U.S . Food, Drug Administration, Machines, Penn, UT Southwestern Medical Center, Associated Press Health, Science Department, Howard Hughes Medical Institute’s Science, Educational Media Group, AP Locations: U.S
CNN —Six supplements that people commonly take for heart health don’t help lower “bad” cholesterol or improve cardiovascular health, according to a study published Sunday, but statins did. Some people believe that common dietary supplements – fish oil, garlic, cinnamon, turmeric, plant sterols and red yeast rice – will lower their “bad” cholesterol. The fatty deposits can block the flow of oxygen and blood that the heart needs to work and the blockage can lead to a heart attack or stroke. He calls these supplements “21st century snake oil.”In the United States, the Dietary Supplement and Health Education Act of 1994 sharply limited the US Food and Drug Administration’s ability to regulate supplements. “The good news, we know statins work,” Khera said.
REUTERS/Dado Ruvic/Illustration/Oct 26 (Reuters) - GSK Plc (GSK.L) came closer to securing its first drug approval since its consumer health spin-off in July as an expert panel of the U.S. health regulator backed an approval for its drug to treat anemia in some patients with chronic kidney disease (CKD). The advisers to the Food and Drug Administration on Wednesday voted 13-3 in favor of the oral drug for patients on dialysis, although GSK was expecting approval for a broader CKD population. The panel, hesitant about backing the drug for patients not on dialysis, voted 11-5 against it for that group, citing increased safety risks such as heart failure. read moreGSK's drug, daprodustat, is the first from the HIF-PH inhibitor class to win U.S. FDA panel's endorsement. The FDA, which usually follows the recommendations of its expert panel, is expected to make its final decision on the drug by Feb. 1.
"Not everybody got flu vaccinated last year, and many people did not get the flu. So that makes us ripe to have potentially a severe flu season." Walensky's warning comes ahead of a CDC report on flu spread expected Friday. Doctors are not required to report each positive flu test to public health officials, so the CDC and others monitor probable flu activity by looking at "influenza-like illnesses." It takes about two weeks after a flu vaccine injection to provide full protection.
Total: 6